Tag Archives: Circulating Cell-Free DNA

Biomarkers in the blood of cancer patients include circulating tumor cells (CTCs), tumor-educated platelets (TEPs), tumor-derived extracellular vesicles (tdEVs), EV-associated miRNA (EV-miRNA), and circulating cell-free DNA (ccfDNA). Because the size and density of biomarkers differ, blood is centrifuged to isolate ...

The development of noninvasive methods to detect and monitor tumors continues to be a bottleneck in oncology research. Circulating cell-free DNA shows great promise, but still requires improvements and additional research before it becomes standard practice. At Cambridge Healthtech Institute’s ...

Select Biosciences Fifth Annual Circulating Biomarkers World Congress 2018 brings together the most up-to-date technologies and advances in this expanding and evolving field.  Our coverage in this conference focuses on the various classes of circulating biomarkers and their emerging applications: Extracellular ...

from Genetic Engineering News by Enal Razvi and Gary Oosta The field of liquid biopsies is rapidly expanding and evolving. Select Biosciences sought to map the dynamics of this evolution by analyzing the scientific literature that comprises not only the ...

Cambridge Healthtech Institute’s Third Annual Circulating Cell-Free DNA Clinical Directions and Emerging Avenues for Early Detection March 10-11, 2016 | Hilton San Francisco Union Square | San Francisco, CA Part of the 23rd International Molecular Medicine Tri-Conference Preliminary Agenda | ...